Immunogenicity and Safety of a Recombinant Tetravalent Dengue Vaccine in Children and Adolescents Ages 9–16 Years in Brazil

Immunogenicity and safety of a recombinant, live-attenuated, tetravalent dengue disease vaccine (CYD-TDV) was evaluated in children/adolescents in Brazil. In this observer-blind, placebo-controlled, phase II single-center study, children/adolescents (ages 9–16 years) were randomized to receive CYD-T...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Dayan, Gustavo H., Garbes, Pedro, Noriega, Fernando, de Sadovsky, Ana Daniela Izoton, Rodrigues, Patricia Marques, Giuberti, Camila, Dietze, Reynaldo
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: The American Society of Tropical Medicine and Hygiene 2013
Pynciau:
Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3854882/
https://ncbi.nlm.nih.gov/pubmed/24189367
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4269/ajtmh.13-0304
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg